SCHEMBL29401747

SCHEMBL29401747

O=C1C(Nc2ccccc2)=CC(=O)c2ncccc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 1.00
SMN1; SMN2 Q16637 4/20 1.00
ALDH1A1 P00352 3/20 1.00
MEN1 O00255 2/20 1.00
KMT2A Q03164 2/20 1.00
TDP1 Q9NUW8 2/20 1.00
GUCY1B2 O75343 1/20 1.00
GUCY1A2 P33402 1/20 1.00
GUCY1A1 Q02108 1/20 1.00
GUCY1B1 Q02153 1/20 1.00
RAB9A P51151 3/20 0.64
LMNA P02545 3/20 0.64
HTT P42858 3/20 0.64
L3MBTL1 Q9Y468 3/20 0.64
MAPK1 P28482 3/20 0.64
NPC1 O15118 2/20 0.64
NFKB1 P19838 1/20 0.64
NFKB2 Q00653 1/20 0.64
RELA Q04206 1/20 0.64
NQO1 P15559 2/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL970943 1.00 MAPT (1.00) MAPTSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL8651660 0.88 MAPT (0.78) MAPTSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL31238099 0.88 MEN1 (0.78) MAPTSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL13940470 0.87 MAPT (0.77) MAPTSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL8656092 0.87 MAPT (0.77) MAPTSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL10506584 0.84 MAPT (0.71) MAPTSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL10506975 0.84 ALDH1A1 (0.71) MAPTSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL10504983 0.84 MAPT (0.71) MAPTSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL8368653 0.83 MAPT (0.70) MAPTSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL8656023 0.81 MAPT (0.68) MAPTSMN1; SMN2ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3956021-A1 METHODS OF TREATING HYPERTENSION WITH ACTIVATORS OF TIE-2 EyePoint Pharmaceuticals, Inc. (US) 2022-02-23 EP disclosed
CN-114072205-A Method of treating hypertension with TIE-2 activator 视点制药公司 2022-02-18 CN disclosed